Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this study is to test how well pembrolizumab shrinks Early‐Stage NK/T‐cell Lymphoma (ENKTL) in participants who have not yet received chemotherapy.
Epistemonikos ID: f3c41407064e503777cde9b15784f6d4ab6f471b
First added on: May 21, 2024